NVIDIA Clara is an accelerated computing platform for healthcare and life sciences, spanning medical imaging, genomics, and drug discovery with AI frameworks and pretrained models.
Clara provides the accelerated computing foundation for healthcare AI. Its medical-imaging frameworks help developers build and deploy imaging models with MONAI, the open-source standard adopted widely in research. For drug discovery, the BioNeMo framework trains and serves biomolecular foundation models at scale, from protein structure to chemistry. Clara also supports genomics pipelines and clinical-grade deployment patterns, including federated learning approaches that let institutions collaborate on models without sharing patient data. NVIDIA’s healthcare partnerships span hospitals, research centers, and pharmaceutical companies, and the platform’s strength is infrastructure: the same GPU-accelerated stack that powers frontier AI research is packaged for the realities of regulated medical data and imaging workloads. Pretrained models, reference pipelines, and developer tools reduce the engineering lift of healthcare AI, while deployment options extend from research clusters to clinical edge hardware inside hospitals. Developer communities and reference architectures accelerate adoption, and NVIDIA’s partnerships with medical device and imaging companies extend the platform into clinical products deployed in hospitals and research centers worldwide.
Many Clara frameworks and models are open source and free. Commercial NVIDIA software, hardware, and cloud instances carry licensing costs, and enterprise support is available through NVIDIA’s healthcare team.
Healthcare AI developers, hospital research groups, and pharmaceutical companies that need accelerated infrastructure and validated frameworks rather than end-user applications. It suits technical organizations building their own medical AI capabilities on a common, well-supported computational foundation.